Sweden's Stille Q3 net sales rise year on year

Stille AB

Today 07:12

((This story was generated using AI and automation, please see
disclaimer https://bit.ly/rtrsnai))
    
Overview
    * Sweden surgical instruments maker's Q3 net sales rose 23% yr/yr, with 16.5% organic growth
    * Adjusted EBITDA for Q3 rose 29% yr/yr
    * Company cites improved delivery performance and strengthened margins as growth drivers

    
Outlook
    * Stille says it is positioned for growth through organic expansion and selective acquisitions
    * Company sees improved delivery performance and strengthened margins supporting future operations

    
Result Drivers
    * ORGANIC GROWTH - Co reported 16.5% organic revenue growth in Q3
    * MARGIN IMPROVEMENT - Gross margin increased to 49.9% from 48.8% in Q3
    * DELIVERY PERFORMANCE - Co said improved delivery performance contributed to results

    
Company press release:  ID:nMFN7p3x73 
    
Key Details
 Metric    Beat/Mis  Actual    Consensu
           s                   s
                               Estimate
 Q3        Miss      SEK       SEK 175
 Revenue             170.60    mln (2
                     mln       Analysts
                               )
 Q3                  SEK        
 Adjusted            33.70     
 EBITDA              mln       
 Q3                  SEK        
 Adjusted            24.50     
 EBIT                mln       
 Q3 EBIT             SEK        
                     28.50     
                     mln       
 Q3                  SEK        
 EBITDA              37.70     
                     mln       
    
Analyst Coverage
    * The one available analyst rating on the shares is "buy"
    * The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy"
    * Wall Street's median 12-month price target for Stille AB is SEK279.00, about 4.1% above its October 22 closing price of SEK268.00
    * The stock recently traded at 23 times the next 12-month earnings vs. a P/E of 24 three months ago

    
Reuters Recommended Reads
    * Oct 22 - Sweden's Arjo Q3 revenue beats estimates, gross margin expands
    * Oct 22 - Sweden's Bonesupport Q3 revenue beats estimates on US segment growth
    * Oct 22 - Sweden's XVIVO Q3 revenue beat expectations on thoracic sales

    
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact .

    (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)